Avicanna Inc. rose 17.6% on Friday, November 13, 2026, on 110,510 shares. The headline around the move:
Avicanna Inc. (AVCN:TSX) closed at $0.100 on November 13, 2026, up 17.65% on the day. The stock trades 64.3% below its 52-week high of $0.280 and 25.0% above its 52-week low of $0.080. Over the past year, it lost 60.8%. Avicanna Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, AVCN closed higher on 66 days (26%). Its best day was November 13, 2026 (+17.65%) and its worst was September 8, 2026 (-19.23%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 6 times.
Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.
Find more stocks like AVCN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.